Andy Lee

Andy Lee has extensive experience in various roles, including co-founder, CFO, and CTO at Vincere Biosciences since September 2018. In this position, they have successfully raised over $6 million for the development of a therapeutic platform targeting the root cause of aging. Andy has led the company in generating four small molecule programs for diseases such as Parkinson's and heart failure, with a potential commercial value of over $1 trillion. Prior to this, Andy co-founded and served as a director at NeuroInitiative, LLC since June 2014. This think tank focused on simulating biology to identify a cure for Parkinson's and collaborated with esteemed institutions such as the University of Oxford and Mayo Clinic. These efforts led to the formation of Vincere Biosciences. Before their involvement in the healthcare industry, Andy worked as the Vice President of Financial Services Engineering at Black Knight Financial Services (formerly known as LPS) from October 2008 to July 2016. During their tenure, they successfully engineered and implemented automation systems for major financial institutions, achieving a 90% market share within three years. Their leadership and management skills were also utilized as the Information System Manager at the Michigan Supreme Court from August 2001 to October 2008.

Andy Lee attended Grand Valley State University from 1997 to 2000, where they earned a Bachelor of Science degree in Computer Science.